Unaudited Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development expense	$ 16,198	$ 30,960	$ 35,050	$ 52,657
General and administrative expense	5,774	6,241	11,379	13,474
Total operating expenses	21,972	37,201	46,429	66,131
Loss from operations	(21,972)	(37,201)	(46,429)	(66,131)
Other income:
Interest income	900	1,460	2,123	2,940
Other income	0	(11)	0	(21)
Total other income	900	1,449	2,123	2,919
Net loss and comprehensive loss	$ (21,072)	$ (35,752)	$ (44,306)	$ (63,212)
Net loss per common share, basic	$ (0.44)	$ (0.75)	$ (0.92)	$ (1.33)
Net loss per common share, diluted	$ (0.44)	$ (0.75)	$ (0.92)	$ (1.33)
Weighted-average shares of common stock outstanding, basic	48,214,893	47,706,426	48,151,176	47,639,977
Weighted-average shares of common stock outstanding, diluted	48,214,893	47,706,426	48,151,176	47,639,977